Pharmacokinetic-Pharmacodynamic Relationships of H1-Antihistamines
- 1 May 1995
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 28 (5) , 419-432
- https://doi.org/10.2165/00003088-199528050-00006
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- H1-Receptor AntagonistsDrug Safety, 1994
- Genomic Cloning, Heterologous Expression and Pharmacological Characterization of a Human Histamine H1 ReceptorBiochemical and Biophysical Research Communications, 1993
- Plasma concentrations and urinary excretion of histamine after inhalation and subcutaneous injection of histamine.British Journal of Clinical Pharmacology, 1993
- Pharmacodynamics and pharmacokinetics of mizolastine (SL 85.0324), a new nonsedative H1 antihistamine.1992
- Comparative safety of H1 antihistamines.1991
- The pharmacology and mechanisms of action of histamine H1‐antagonistsClinical and Experimental Allergy, 1990
- TerfenadineDrugs, 1990
- Rational Use of Antihistamines in Allergic Dermatological ConditionsDrugs, 1989
- The pharmacokinetics and pharmacodynamics of terfenadine in childrenJournal of Allergy and Clinical Immunology, 1987
- Aspects of histamine metabolismInflammation Research, 1987